tiprankstipranks
Advertisement
Advertisement

HUMA Stock Latest News

Largest borrow rate increases among liquid names
The FlyLargest borrow rate increases among liquid names
4d ago
ET
KDK
Humacyte reports Symvess under contract with Strategic Acquisition Center of VA
PremiumThe Fly
Humacyte reports Symvess under contract with Strategic Acquisition Center of VA
5d ago
HUMA
Humacyte price target raised to $1.50 from $1 at TD Cowen
PremiumThe Fly
Humacyte price target raised to $1.50 from $1 at TD Cowen
11d ago
HUMA
Humacyte Earnings Call Balances Growth With Losses
PremiumCompany Announcements
Humacyte Earnings Call Balances Growth With Losses
12d ago
HUMA
Humacyte: Buy Rating Reaffirmed as Jennings Lifts Price Target to $1.50 on Broad Growth Runway and Key Clinical Catalysts
PremiumRatings
Humacyte: Buy Rating Reaffirmed as Jennings Lifts Price Target to $1.50 on Broad Growth Runway and Key Clinical Catalysts
12d ago
HUMA
Humacyte reports Q1 EPS (9c), consensus (12c)
PremiumThe FlyHumacyte reports Q1 EPS (9c), consensus (12c)
12d ago
HUMA
Humacyte names Todd Rasmussen chief surgical officer
Premium
The Fly
Humacyte names Todd Rasmussen chief surgical officer
13d ago
HUMA
Humacyte Receives Nasdaq Notice on Minimum Bid Requirement
Premium
Company Announcements
Humacyte Receives Nasdaq Notice on Minimum Bid Requirement
17d ago
8K
HUMA
Humacyte (HUMA) Motion to Dismiss Ruling Keeps Key Securities Claims Alive 
PremiumClass Action
Humacyte (HUMA) Motion to Dismiss Ruling Keeps Key Securities Claims Alive 
21d ago
HUMA
Analyst Reiterates Buy on Humacyte, Citing Hemodialysis Upside and KOL Support, Keeps $1 Price Target Unchanged
PremiumRatings
Analyst Reiterates Buy on Humacyte, Citing Hemodialysis Upside and KOL Support, Keeps $1 Price Target Unchanged
27d ago
HUMA
Humacyte Regains Global Rights to Symvess Vascular Graft
PremiumCompany Announcements
Humacyte Regains Global Rights to Symvess Vascular Graft
1M ago
8K
HUMA
Humacyte realigns ex-U.S. rights to Symvess through Fresenius Medical pact
PremiumThe Fly
Humacyte realigns ex-U.S. rights to Symvess through Fresenius Medical pact
1M ago
FMS
HUMA
Humacyte announces Israeli Ministry of Health acceptance of MAA for Symvess
PremiumThe FlyHumacyte announces Israeli Ministry of Health acceptance of MAA for Symvess
1M ago
HUMA
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
RUM
YSS
Humacyte price target lowered to $1.50 from $3.50 at Barclays
Premium
The Fly
Humacyte price target lowered to $1.50 from $3.50 at Barclays
2M ago
HUMA
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
VOD
VST
Humacyte downgraded to Speculative Buy from Buy at Benchmark
PremiumThe Fly
Humacyte downgraded to Speculative Buy from Buy at Benchmark
2M ago
HUMA
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
KC
FRO
Humacyte price target lowered to $1 from $3.50 at TD Cowen
PremiumThe Fly
Humacyte price target lowered to $1 from $3.50 at TD Cowen
2M ago
HUMA
Humacyte price target lowered to $1 from $3 at Piper Sandler
PremiumThe FlyHumacyte price target lowered to $1 from $3 at Piper Sandler
2M ago
HUMA
Humacyte: Near-Term Commercial Headwinds but Platform Catalysts Support Long-Term Upside and Buy Rating
Premium
Ratings
Humacyte: Near-Term Commercial Headwinds but Platform Catalysts Support Long-Term Upside and Buy Rating
2M ago
HUMA
Morning Movers: AstraZeneca jumps following tozorakimab trial results
Premium
The Fly
Morning Movers: AstraZeneca jumps following tozorakimab trial results
2M ago
AGX
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >